Cargando…
Molnupiravir and Its Antiviral Activity Against COVID-19
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitutes a major worldwide public health threat and economic burden. The pandemic is still ongoing and the SARS-CoV-2 variants are still emerging constantly, resulting in an urg...
Autores principales: | Tian, Lili, Pang, Zehan, Li, Maochen, Lou, Fuxing, An, Xiaoping, Zhu, Shaozhou, Song, Lihua, Tong, Yigang, Fan, Huahao, Fan, Junfen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013824/ https://www.ncbi.nlm.nih.gov/pubmed/35444647 http://dx.doi.org/10.3389/fimmu.2022.855496 |
Ejemplares similares
-
Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021) -
Overview of Breastfeeding Under COVID-19 Pandemic
por: Pang, Zehan, et al.
Publicado: (2022) -
The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era
por: Fan, Huahao, et al.
Publicado: (2022) -
COVID-19 vaccine development: milestones, lessons and prospects
por: Li, Maochen, et al.
Publicado: (2022) -
The Benefits of Breastfeeding Still Outweigh the Risks of COVID-19 Transmission
por: Lou, Fuxing, et al.
Publicado: (2021)